BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22986744)

  • 1. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.
    Bai RY; Staedtke V; Lidov HG; Eberhart CG; Riggins GJ
    Cancer Res; 2012 Nov; 72(22):5988-6001. PubMed ID: 22986744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
    Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
    Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
    Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M
    Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
    Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H
    Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.
    Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H
    Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
    Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
    PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas.
    Bai R; Siu IM; Tyler BM; Staedtke V; Gallia GL; Riggins GJ
    Neuro Oncol; 2010 Jul; 12(7):655-63. PubMed ID: 20511190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
    Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
    J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
    Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
    Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.
    Kaur R; Aiken C; Morrison LC; Rao R; Del Bigio MR; Rampalli S; Werbowetski-Ogilvie T
    Dis Model Mech; 2015 Oct; 8(10):1295-309. PubMed ID: 26398939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
    Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
    de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.
    Bhoopathi P; Chetty C; Dontula R; Gujrati M; Dinh DH; Rao JS; Lakka SS
    Cancer Res; 2011 Jul; 71(14):4908-19. PubMed ID: 21613407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells.
    Wortham M; Jin G; Sun JL; Bigner DD; He Y; Yan H
    PLoS One; 2012; 7(4):e36211. PubMed ID: 22558385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.
    Zagozewski J; Shahriary GM; Morrison LC; Saulnier O; Stromecki M; Fresnoza A; Palidwor G; Porter CJ; Forget A; Ayrault O; Hawkins C; Chan JA; Vladoiu MC; Sundaresan L; Arsenio J; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
    Nat Commun; 2020 Jul; 11(1):3627. PubMed ID: 32686664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
    Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
    Boon K; Eberhart CG; Riggins GJ
    Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
    Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
    Shi JA; Lu DL; Huang X; Tan W
    Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.